about
Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data.Hemolytic uremic syndrome. Recurrence after renal transplantation. Groupe Coopératif de l'Ile-de-France (GCIF).A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients.Fumagillin for treatment of intestinal microsporidiosis in renal transplant recipients.Renal biopsy practice in France: results of a nationwide study.Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation[Renal biopsy practice: results of a French study and recommendations].Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejection.Human endothelial cells generate Th17 and regulatory T cells under inflammatory conditions.Intravenous immunoglobulins and transplantation for patients with anti-HLA antibodies.Dual Invasive Infection with Phaeoacremonium parasiticum and Paraconiothyrium cyclothyrioides in a Renal Transplant Recipient: Case Report and Comprehensive Review of the Literature of Phaeoacremonium Phaeohyphomycosis.Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.Long term outcomes of transplantation using kidneys from expanded criteria donors: prospective, population based cohort study.Antibody-Mediated Rejection Due to Preexisting versus De Novo Donor-Specific Antibodies in Kidney Allograft Recipients.Candida albicans arteritis transmitted by conservative liquid after renal transplantation: a report of four cases and review of the literature.Early epithelial phenotypic changes predict graft fibrosis.Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use.The evaluation of renal function and disease in patients with cirrhosis.Immunological function of the endothelial cell within the setting of organ transplantation.Regulation of the CD4+ T cell allo-immune response by endothelial cells.New insights in antibody-mediated rejection.Donor Specific Antibodies are not only directed against HLA-DR: Minding your Ps and Qs.Evidence for an important role of both complement-binding and noncomplement-binding donor-specific antibodies in renal transplantation.7th International Immunoglobulin Conference: Transplantation.Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score.Non-human leukocyte antigen antibodies reactive with endothelial cells could be involved in early loss of renal allografts.The Seville expert workshop for progress in posttransplant lymphoproliferative disorders.Chronic interstitial nephritis in an HIV type-1-infected patient receiving ritonavir-boosted atazanavir.Can solid phase assays be better utilized to measure efficacy of antibody removal therapies?Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.Nephron sparing surgery is a feasible and efficient treatment of T1a renal cell carcinoma in kidney transplant: a prospective series from a single center.Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.HLA Class II Antibody Activation of Endothelial Cells Promotes Th17 and Disrupts Regulatory T Lymphocyte Expansion.Optimization of an elispot assay to detect cytomegalovirus-specific CD8+ T lymphocytes.Natural Killer Lymphocytes Are Dysfunctional in Kidney Transplant Recipients on Diagnosis of Cancer.Assessing Antibody Strength: Comparison of MFI, C1q, and Titer Information.Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation.The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology.Acute enteritis associated with Coxsackievirus A19 in a kidney transplant patient.Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept study.
P50
Q30871643-965A8CD0-72C1-4BFE-BC04-8DA0C6F20302Q33332155-4D7049B7-C8D7-4AEF-846D-B080DEDF7E1EQ33347170-F93584FB-9E29-413F-8B52-DE24B6B707A9Q33390811-9394A8A1-FA09-45FE-A937-CE705E451FDAQ33577706-A27F46B4-26D3-4763-ABFB-77667A4BDB13Q34124202-14895245-25D2-4208-A7FE-2BD92E2892DCQ34198699-2263552D-3BCF-4D65-8701-3F6DE19073A2Q34260097-3F8C99C4-9466-41EB-AA2C-651001D52611Q34583004-EC1C37CD-C0FE-4F19-AAAD-D4203381C71BQ35611406-B3CE712C-F156-4ACF-BD16-68D50A33FDB0Q35757580-F2B0A68D-2A8A-4BA3-8BEB-8AB38FFF39A6Q35790552-D0ED57D4-581B-4629-82D2-E56951E3E013Q35907637-C1B6E115-376F-4441-B6FD-FAF869556230Q36296061-950966AB-30DF-4C30-A457-1442C01E36E9Q36653141-CE785276-8D01-49CA-8149-86715EEEF1BAQ36796755-703385B9-A950-49E2-8367-8D1390E828EBQ37351865-3D732195-AAA2-499C-8C6A-556CA3B3F533Q37698770-CE24C162-D46F-44AB-8B5F-139D874C9B16Q37885017-71988359-08C6-414A-9F66-02B46A9BF643Q38027653-4FE83E88-270D-4829-82E9-35D904A0846CQ38248369-9A2F8635-A727-4530-BA0A-3E7EFC05FE1AQ38802843-863E1537-A5C0-4564-94DA-0EE95957CA5CQ38878451-F2743D70-E6BC-4D8D-A9F9-1617057F4A9EQ39067357-CCBE29F9-0BF0-45A3-8A50-AF7535F69DC4Q39464615-B2177A80-CFDB-48BC-A556-780484CFA084Q39534801-4354D269-90BC-49B3-B9F9-17BF95C13CCBQ39550390-C214FFD4-35E9-4DCA-9BC5-71763C8E14C1Q39560419-255D4514-C1F2-4FBC-B959-3972E3A96D00Q39706871-46DA5A80-1670-4985-B7F7-D178236CE91CQ39904553-ABB06479-22B0-4C5B-A66E-EA027BB2EB0AQ40044981-14639C1D-4248-44AD-8120-03145A91953CQ40181825-6CE37648-8D57-4FE7-B806-09FA7454CD65Q40266578-1237DC7F-38CC-4921-A5CE-8C077427975AQ40489549-3E651CED-7B68-403E-9FA2-9FA8E3C3F010Q40821887-AFFD2401-2827-4D90-9A7F-9848AB375240Q40990548-01093C3A-BC16-48B7-89EE-BF0CDA55B328Q42111937-4C37E74E-3200-4589-AF24-EB2C7B7140B2Q42174325-57D83C82-B563-4422-A9BC-5FF3EF7646FCQ42224060-51CBF71C-C1D5-4E5A-A0F0-C9B8B2049B95Q42620122-A38C5BDF-92C8-4D14-BDA7-673ED332D900
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Denis Glotz
@ast
Denis Glotz
@en
Denis Glotz
@es
Denis Glotz
@nl
type
label
Denis Glotz
@ast
Denis Glotz
@en
Denis Glotz
@es
Denis Glotz
@nl
prefLabel
Denis Glotz
@ast
Denis Glotz
@en
Denis Glotz
@es
Denis Glotz
@nl
P214
P106
P1153
7006587565
P214
P31
P496
0000-0001-5258-4237
P7859
viaf-14840506